Quest Diagnostics Incorporated
$200.41
▼
-2.26%
2026-04-22 10:12:13
www.questdiagnostics.com
NYQ: DGX
Explore Quest Diagnostics Incorporated stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$22.16 B
Current Price
$200.41
52W High / Low
$213.5 / $160.02
Stock P/E
22.15
Book Value
$65.18
Dividend Yield
1.76%
ROCE
11.16%
ROE
14.75%
Face Value
—
EPS
$9.05
Exp Qtr EPS
—
Sector
Healthcare
Industry
Diagnostics & Research
Employees
46,000
Beta
0.65
Debt / Equity
90.38
Current Ratio
1.04
Quick Ratio
0.96
Forward P/E
16.68
Price / Sales
1.92
Enterprise Value
$27.32 B
EV / EBITDA
12.56
EV / Revenue
2.48
Rating
Buy
Target Price
$217.88
EPS Forecast (FY)
—
Pros
- Core market and financial snapshot is available for screening.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Myriad Genetics, Inc. | $5.14 | — | $484.84 M | — | -11.84% | -23.51% | $8.59 / $3.76 | $3.94 |
| 2. | bioAffinity Technologies, Inc. | $2.69 | — | $12.87 M | — | -131.93% | -3.02% | $17.44 / $0.69 | $1.62 |
| 3. | Precipio, Inc. | $28.15 | — | $50.21 M | — | -6.84% | -2.72% | $29.8 / $5.19 | $8.18 |
| 4. | Twist Bioscience Corporation | $61.88 | — | $3.79 B | — | -24.75% | -16.79% | $62.09 / $23.3 | $7.44 |
| 5. | Veracyte, Inc. | $33.45 | 39.66 | $2.63 B | — | 5.82% | 5.34% | $50.71 / $22.61 | $16.5 |
| 6. | Labcorp Holdings Inc. | $271.17 | 25.93 | $22.36 B | 1.07% | 9.74% | 10.51% | $293.72 / $209.38 | $104.86 |
| 7. | FONAR Corporation | $18.8 | 15.61 | $117.93 M | — | 5.81% | 6.01% | $18.86 / $12 | $27.01 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 2.81 B | 2.82 B | 2.76 B | 2.65 B | 2.62 B |
| Operating Profit | 386 M | 386 M | 438 M | 346 M | 361 M |
| Net Profit | 245 M | 245 M | 282 M | 220 M | 222 M |
| EPS in Rs | 2.21 | 2.21 | 2.55 | 1.99 | 2.01 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 11.04 B | 9.87 B | 9.25 B | 9.88 B |
| Operating Profit | 1.56 B | 1.35 B | 1.26 B | 1.43 B |
| Net Profit | 992 M | 871 M | 854 M | 946 M |
| EPS in Rs | 8.96 | 7.87 | 7.72 | 8.55 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 16.23 B | 16.15 B | 14.02 B | 12.84 B |
| Total Liabilities | 8.94 B | 9.26 B | 7.6 B | 6.83 B |
| Equity | 7.17 B | 6.78 B | 6.31 B | 5.89 B |
| Current Assets | 2.38 B | 2.39 B | 2.37 B | 1.9 B |
| Current Liabilities | 2.28 B | 2.17 B | 1.81 B | 1.55 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 1.89 B | 1.33 B | 1.27 B | 1.72 B |
| Investing CF | -631 M | -2.55 B | -1.06 B | -543 M |
| Financing CF | -1.39 B | 1.08 B | 160 M | -1.73 B |
| Free CF | 1.36 B | 909 M | 864 M | 1.31 B |
| Capex | -527 M | -425 M | -408 M | -404 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 6.7% | -6.38% | — | — |
| Earnings Growth % | 1.99% | -9.73% | — | — |
| Profit Margin % | 8.82% | 9.23% | 9.57% | — |
| Operating Margin % | 13.63% | 13.64% | 14.45% | — |
| Gross Margin % | 32.86% | 33% | 34.74% | — |
| EBITDA Margin % | 19.19% | 18.72% | 18.42% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-04-06 | $0.86 |
| 2026-01-13 | $0.8 |
| 2025-10-03 | $0.8 |
| 2025-07-07 | $0.8 |
| 2025-04-07 | $0.8 |
Stock Splits
No stock split history available.